CRISPR/Cas9 technology generated a 134 bp deletion in exon 2. RT-PCR confirmed absence of mRNA in the gastrocnemius muscle and Western blot analysis confirmed absence of protein in the plasma. (J:322617)
查看原文 参与反馈
CRISPR/Cas9 technology generated a 134 bp deletion in exon 2. RT-PCR confirmed absence of mRNA in the gastrocnemius muscle and Western blot analysis confirmed absence of protein in the plasma. (J:322617)